|
|
|
Volumn 104, Issue 8, 2001, Pages
|
|
Bush stem cell decision limits research to existing cell lines.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
BIOETHICS;
CYTOLOGY;
ECONOMICS;
FINANCIAL MANAGEMENT;
HEALTH CARE POLICY;
HUMAN;
LEGAL ASPECT;
RELIGION;
RESEARCH;
STANDARD;
STEM CELL;
UNITED STATES;
CHEMICALLY INDUCED DISORDER;
DOSE RESPONSE;
DRUG CONTROL;
FOOD AND DRUG ADMINISTRATION;
POSTMARKETING SURVEILLANCE;
RHABDOMYOLYSIS;
GOVERNMENT;
HEALTH CARE DELIVERY;
HEALTH CARE PLANNING;
MEDICAID;
BIOETHICS;
FINANCING, GOVERNMENT;
HEALTH POLICY;
HUMANS;
RELIGION AND SCIENCE;
RESEARCH;
STEM CELLS;
UNITED STATES;
ANTICHOLESTEREMIC AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG AND NARCOTIC CONTROL;
GEMFIBROZIL;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
PRODUCT SURVEILLANCE, POSTMARKETING;
PYRIDINES;
RHABDOMYOLYSIS;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
HEALTH PLANNING;
HEALTH SERVICES ACCESSIBILITY;
MEDICAID;
STATE HEALTH PLANS;
UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES;
CERIVASTATIN;
GEMFIBROZIL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
PYRIDINE DERIVATIVE;
|
|
EID: 0035928881
PISSN: 15244539
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (31)
|
|
References (0)
|
